MERS (Middle East Respiratory Syndrome)
5 clinical trials · Condition
◉ Watch MERS (Middle East Respiratory Syndrome)
| Record | Firm | Date |
|---|---|---|
| Safety and Immunogenicity of the Candidate Vaccine MVA-MERS-S_DF-1 Against MERS (NCT04119440) | Universitätsklinikum Hamburg-Eppendorf | 2021-04-16 |
| Study of Safety and Immunogenicity of BVRS-GamVac (NCT04130594) | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | 2019-11-07 |
| Study of Safety and Immunogenicity of BVRS-GamVac-Combi (NCT04128059) | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | 2019-11-06 |
| Safety and Immunogenicity of a Candidate MERS-CoV Vaccine (MERS001) (NCT03399578) | University of Oxford | 2018-03-14 |
| Safety, Tolerability and Immunogenicity of Vaccine Candidate MVA-MERS-S (NCT03615911) | Marylyn Addo | 2017-11-28 |
Track MERS (Middle East Respiratory Syndrome) automatically
Every clearance here is in the API, with alerts when new ones post.